Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Phenethyl bromide | HCID 7666 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 1,8-Diazabicyclo[5.4.0]undec-2-ene | HCID 9812821 | — |
| Reactant | HCID 21993635 | HCID 21993635 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | HCID 21994029 | HCID 21994029 | 44% |
Reaction Steps
(2-Bromoethyl)benzene (312 mg, 1.68 mmol) was added to a stirred solution of N-[3-(2-oxopiperazin-1-yl)propan-1-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide dihydrochloride (610 mg, 1.42 mmol), triethylamine (722 mg, 7.13 mmol), sodium iodide (255 mg, 1.70 mmol) and 1,8-diazabicyclo[5.4.0]undecene (438 mg, 2.88 mmol) in acetonitrile (20 ml) at room temperature. After refluxing under nitrogen for 2 days, the reaction mixture was concentrated in vacuo. The residue was dissolved in water and extracted with chloroform. The extract was washed with brine, dried over MgSO4 and concentrated in vacuo. The residue was chromatographed on silica gel(20 g) with Ethyl acetate-Methanol (8:1) to give N-[3-[4-(2-phenylethan-1-yl)-2-oxopiperazin-1-yl]propan-1-yl]-5-thia-1,8b-diazaacenaphthylene-4-carboxamide as a purple amorphous powder (288 mg, 44%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06235731B1 |
|---|
| Source dataset | uspto-grants-2001_05 |
|---|
| ORD ID | ord-c147277a6b6d4ec4933ffa3b07ceb944 |
|---|
| Source note | uspto-grants-2001_05 |
|---|